Medical device correction: Omnipod (Insulet – May 2026)

Jun. 2026Pharmacy Updates

Insulet Corporation Inc. has announced a medical device correction for certain Omnipod Pods. These pods are wearable devices that are used to deliver insulin.

The pods are being corrected because some pods may have a small tear in the tubing that delivers insulin. This tear could cause insulin to leak outside the pod instead of being fully infused into the body as intended. If insulin is not delivered properly, the person wearing the pod may experience high blood glucose levels. This can lead to a serious medical condition called diabetic ketoacidosis (DKA), which requires immediate medical treatment.

Insulet advises that customers should visit omnipod.com/mdc/check-pod-lot to learn if their pods are affected by this correction and request replacement pods at no cost.

If a customer is currently wearing a pod from an affected lot, Insulet advises that they should stop wearing it and replace it with a pod from an unaffected lot.

As of May 26, Insulet had received 24 reports of serious adverse events associated with high blood glucose levels, including hospitalization and DKA. No deaths had been reported. This issue does not affect continuous glucose monitoring (CGM) systems or CGM readings.

To learn more about this recall, you can take one or more of the steps below.

  • Talk to your doctor or pharmacist.
  • Call Insulet Product Support at 1-800-641-2049 (available 24/7). TTY users should call 711.
  • Use the live agent chat at omnipod.com/current-podders.
  • Visit the FDA website.

Recent Announcements

CME Webinar: Lifestyle Medicine in Practice: Evidence‑Based Strategies for Chronic Disease Care

Please join us for a live, CME-accredited webinar on Wednesday, Sept. 23 from noon to 1 p.m., that will provide an overview on lifestyle medicine. Participants will learn how to integrate six core domains—nutrition, physical activity, sleep, stress management, avoidance of risky substances, and social connection—into routine care using practical tools such as brief counseling, motivational interviewing, and team-based strategies.
Sep. 2026Education/Webinars

Voluntary nationwide recall: Thyroid (Vitruvias – August 2026)

Vitruvias Therapeutics Inc. is recalling one lot, lot 504950, of Thyroid Tablets, USP 30 mg. Thyroid Tablet is used to treat hypothyroidism (underactive thyroid).
Sep. 2026Pharmacy Updates

Voluntary nationwide recall: Dextrose (Baxter – August 2026)

Baxter International Inc. is recalling one lot (lot Y495066) of 70% Dextrose Injection. Dextrose is used to replenish calories and fluid in certain situations.
Sep. 2026Pharmacy Updates